References
- Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69–90
- Adelson KB, Loprinzi CL, Hershman DL. Treatment of hot flushes in breast and prostate cancer. Expert Opinion Pharmacother 2005;6:1095–106
- Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW. Executive summary of the Stages of Reproductive Aging Workshop+ 10: addressing the unfinished agenda of staging reproductive aging. Climacteric 2012;15:105–14
- Othman AH, Zaky AH. Management of hot flushes in breast cancer survivors: comparison between stellate ganglion block and pregabalin. Pain Med 2014;15:410–17
- Frisk J. Managing hot flushes in men after prostate cancer: a systematic review. Maturitas 2010;65:15–22
- Grunfeld EA, Halliday A, Martin P, et al. Andropause syndrome in men treated for metastatic prostate cancer: a qualitative study of the impact of symptoms. Cancer Nurs 2013;35:63–9
- Walker LM, Tran S, Robinson JW. Luteinizing hormone-releasing hormone agonists: a quick reference for prevalence rates of potential adverse effects. Clin Genitourin Cancer 2013;11:375–84
- Dalal S, Zhukovsky DS. Pathophysiology and management of hot flashes. J Support Oncol 2006;4:315–20
- Hanisch LJ, Gooneratne NS, Soin K, et al. Sleep and daily functioning during androgen deprivation therapy for prostate cancer. Eur J Cancer Care 2011;20:549–54
- Nishiyama T, Kanazawa S, Watanabe R, et al. Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy. Int J Urol 2004;11:735–41
- Spetz A-C, Zetterlund E-L, Varenhorst E, et al. Incidence and management of hot flashes in prostate cancer. J Support Oncol 2001;1:263–72
- Ulloa EW, Salup R, Patterson SG, et al. Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer. Psychooncology 2009;18:598–605
- Baum N, Torti D. Management of hot flashes in men with prostate cancer. Geriat Aging 2003;6:43–6
- Spetz A-C, Hammar M, Lindberg B, Spangberg A, Varenhorst E. Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate. J Urol 2001;166:517–20
- Graham J, Baker M, Macbeth F, et al. Guidelines: Diagnosis and treatment of prostate cancer: summary of NICE guidance. BMJ 2008;336:610
- Fisher WI, Johnson AK, Elkins GR, et al. Risk factors, pathophysiology, and treatment of hot flashes in cancer. CA Cancer J Clin 2013;63:167–92
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11–30
- Khan A, Lewis R, Hughes S. Managing hot flushes in men receiving androgen deprivation therapy for prostate cancer. Trends Urol Men Health 2014;5:31–3
- Hanisch LJ, Palmer SC, Donahue A, Coyne JC. Validation of sternal skin conductance for detection of hot flashes in prostate cancer survivors. Psychophysiology 2007;44: 189–93
- Mann E, Hunter MS. Concordance between self-reported and sternal skin conductance measures of hot flushes in symptomatic menopausal women: a systematic review. Menopause 2011;18:709–22
- Hanisch LJ, Palmer S, Marcus S, Hantsoo L, Vaughn DJ, Coyne JC. Comparison of objective and patient-reported hot flash measures in men with prostate cancer. J Support Oncol 2009;7:131–5
- Hunter MS, Mann E. A cognitive model of menopausal hot flushes and night sweats. J Psychosom Res 2010;69: 491–501
- Ayers B, Hunter MS. Health-related quality of life of women with menopausal hot flushes and night sweats. Climacteric 2013;16:235–9
- Hunter MS, Chilcot J. Testing a cognitive model of menopausal hot flushes and night sweats. J Psychosom Res 2013;74:307–12
- Stefanopoulou E, Hunter MS. Symptom perception in healthy menopausal women: Can we predict concordance between subjective and physiological measures of vasomotor symptoms? Am J Hum Biol 2014;26:389–94
- Kumari M, Stafford M, Marmot M. The menopausal transition was associated in a prospective study with decreased health functioning in women who report menopausal symptoms. J Clin Epidemiol 2005;58:719–27
- Archer DF, Sturdee DW, Baber R, et al. Menopausal hot flushes and night sweats: where are we now? Climacteric 2011;14:515–28
- Hunter MS, Gentry-Maharaj A, Ryan A, et al. Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10,418 British women aged 54–65. BJOG 2012;119:40–50
- Hunter MS, Liao KL. A psychological analysis of menopausal hot flushes. Br J Clin Psychol 1995;34:589–99
- Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361–70
- Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Social Behav 1983;24:385–96
- Barsky AJ, Wyshak G, Klerman GL. The Somatosensory Amplification Scale and its relationship to hypochondriasis. J Psychiatr Res 1990;24:323–34
- Herzberg PY, Glaesmer H, Hoyer J. Separating optimism and pessimism: A robust psychometric analysis of the Revised Life Orientation Test (LOT-R). Psychol Assess 2006;18:433–8
- Hunter MS, Sharpley CF, Stefanopoulou E, et al. The hot flush beliefs and behaviour scale for men (HFBBS-Men) undergoing treatment for prostate cancer. Maturitas 2014;79:464–70
- Fayers P, Bottomley A. Quality of life research within the EORTC – the EORTC QLQ-C30. Eur J Cancer 2002;38:125–33
- Bahr DE, Webster JG, Grady D, et al. Miniature ambulatory skin conductance monitor and algorithm for investigating hot flash events. Physiol Meas 2014;35:95–110
- Rand K, Otte J, Flockhart D, et al. Modeling hot flushes and quality of life in breast cancer survivors. Climacteric 2011;14:171–80
- Hanisch LJ, Gehrman PR. Circadian rhythm of hot flashes and activity levels among prostate cancer patients on androgen deprivation therapy. Aging Male 2011;14:243–8
- Thurston RC, Hernandez J, Del Rio JM, De La Torre F. Support Vector Machines to improve physiologic hot flash measures: Application to the ambulatory setting. Psychophysiology 2011;48:1015–21
- Watts S, Leydon G, Birch B, et al. Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open 2014;4:e003901
- Thurston RC, Bromberger JT, Joffe H, et al. Beyond frequency: who is most bothered by vasomotor symptoms? Menopause 2008;15:841–7
- Carpenter JS, Igega CM, Otte JL, Burns DS, Yu M, Wu J. Somatosensory amplification and menopausal symptoms in breast cancer survivors and midlife women. Maturitas 2014;78:51–5
- Grassi L, Caruso R, Nanni MG. Somatization and somatic symptom presentation in cancer: A neglected area. Int Rev Psychiatr 2013;25:41–51
- Ayers B, Smith M, Hellier J, et al. Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial. Menopause 2012;19:749–59
- Mann E, Smith MJ, Hellier J, et al. Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol 2012;13:309–18
- Chilcot J, Norton S, Hunter MS. Cognitive behaviour therapy for menopausal symptoms following breast cancer treatment: who benefits and how does it work? Maturitas 2014;78:56–61
- Duijts SF, Van Beurden M, Oldenburg HS, et al. Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: Results of a randomized, controlled, multicenter trial. J Clin Oncol 2013;30:4124–33
- Stefanopoulou E, Yousaf O, Grunfeld EA, Hunter MS. A randomised controlled trial of a brief cognitive behavioural intervention for men who have hot flushes following prostate cancer treatment (MANCAN). Psychooncology 2015;24:1159–66